BRIEF published on 12/10/2024 at 10:51, 1 year 1 month ago Threshold crossing by Cyrille Tupin at ABIONYX PHARMA Voting Rights Actions Threshold Crossing ABIONYX Pharma Cyrille Tupin
PRESS RELEASE published on 12/10/2024 at 10:46, 1 year 1 month ago Franchissement de seuil Déclaration de franchissement de seuil par M. Cyrille Tupin concernant ABIONYX PHARMA. Détention de 4,56% du capital et 6,06% des droits de vote Déclaration Droits De Vote Franchissement De Seuil ABIONYX Pharma Cyrille Tupin
BRIEF published on 11/14/2024 at 19:05, 1 year 2 months ago ABIONYX Pharma : Bilan financier du troisième trimestre 2024 Chiffre D'affaires Biotechnologie Trésorerie ABIONYX Pharma T3 2024
BRIEF published on 11/14/2024 at 19:05, 1 year 2 months ago ABIONYX Pharma: Third quarter 2024 financial report Biotechnology Treasury Turnover Q3 2024 ABIONYX Pharma
PRESS RELEASE published on 11/14/2024 at 19:00, 1 year 2 months ago Information financière trimestrielle / Information financière du troisième trimestre ABIONYX Pharma communique son chiffre d'affaires et sa trésorerie du 3ème trimestre 2024. Retransmission de l'AGE le 28 novembre 2024 Chiffre D'affaires Trésorerie ABIONYX Pharma 3ème Trimestre 2024 Retransmission AGE
PRESS RELEASE published on 11/14/2024 at 19:00, 1 year 2 months ago Quarterly financial reporting / Third quarter financial report ABIONYX Pharma reports Q3 2024 revenue of €3.4m and cash position of €4.1m before IRIS Pharma's CIR receipt. General Meeting on November 28, 2024, at 2.00 pm CET Cash Position General Meeting Biotech Company ABIONYX Pharma Revenue Update
BRIEF published on 10/24/2024 at 19:35, 1 year 3 months ago ABIONYX Pharma présente les résultats de l'étude RACERS ABIONYX Pharma CER-001 Brain-fog Neuro-inflammation Kidney Week
BRIEF published on 10/24/2024 at 19:35, 1 year 3 months ago ABIONYX Pharma presents the results of the RACERS study ABIONYX Pharma CER-001 Brain Fog Kidney Week Neuroinflammation
PRESS RELEASE published on 10/24/2024 at 19:30, 1 year 3 months ago Informations privilégiées / Autres communiqués ABIONYX Pharma présente les résultats cliniques de l'étude RACERS sur le brouillard cérébral et l'efficacité de CER-001 au congrès annuel 2024 de l'ASN. Nouvelles données sur la neuro-inflammation et les troubles cognitifs ASN ABIONYX Pharma CER-001 Brain-fog Étude RACERS
PRESS RELEASE published on 10/24/2024 at 19:30, 1 year 3 months ago Inside Information / Other news releases ABIONYX Pharma's RACERS study on CER-001 shows positive impact on cognitive impairment in brain-fog patients, presenting new clinical results at ASN 2024 Annual Meeting. Potential treatment for neuroinflammation ABIONYX Pharma CER-001 Brain-fog Neuroinflammation RACERS Study
Published on 01/31/2026 at 03:15, 1 day 18 hours ago Empress Royalty Announces Grant Of Restricted Share Units
Published on 01/31/2026 at 01:40, 1 day 19 hours ago Star Copper Announces Grant of RSUs, Stock Options and PSUs
Published on 01/30/2026 at 23:00, 1 day 22 hours ago Avidian Gold Corp. Announces Director Resignation
Published on 02/01/2026 at 20:25, 1 hour 2 minutes ago WHO Makes Historic Pivot to County-Level Governance, Validating "Bottom-Up" Climate-Health Model in Tropical Southern China
Published on 01/31/2026 at 15:54, 1 day 5 hours ago EQS-Adhoc: Wolford AG: Capital increase will not be implemented
Published on 01/31/2026 at 12:25, 1 day 9 hours ago JOHNNIE WALKER TOASTS MUSIC'S BIGGEST WEEKEND WITH THE GO GO HIGHBALL
Published on 01/31/2026 at 02:45, 1 day 18 hours ago CANADA BACKS NEW DEFENCE, SECURITY AND RESILIENCE BANK
Published on 01/30/2026 at 22:00, 1 day 23 hours ago Nebius Group N.V. announces date of fourth quarter and full year 2025 results and conference call
Published on 01/30/2026 at 18:40, 2 days 2 hours ago ICADE - Bilan semestriel du contrat de liquidite
Published on 01/30/2026 at 17:45, 2 days 3 hours ago Schneider Electric launches a capital increase reserved for employees
Published on 01/30/2026 at 17:45, 2 days 3 hours ago Schneider Electric lance une augmentation de capital réservée aux salariés
Published on 01/30/2026 at 08:30, 2 days 12 hours ago Claude Bernard lance Senior+, un assistant IA conçu pour améliorer la prise en charge des patients les plus âgés
